Pegfilgrastim
Links shared publicly online about this topic
ingentaconnect Pharmacokinetics and Pharmacodynamics of Pegfilgrastim
ingentaconnect.com — “ingentaconnect Pharmacokinetics and Pharmacodynamics of Pegfilgrastim” View full resource at ingentaconnect.com
Most Recently Shared on April 6, 2011 at 8:14 am By:
Drugs and Devices OW OW Health
Pharmacokinetics and Pharmacodynamics of Pegfilgrastim: (Source: Clinical Pharmacokinetics)MedWorm Sponsor Messa... http://bit.ly/hWfbUm
ingentaconnect Azacitidine/pegfilgrastim: Various toxicities in elderly patients...
ingentaconnect.com — “ingentaconnect Azacitidine/pegfilgrastim: Various toxicities in elderly patients...” View full resource at ingentaconnect.com
Most Recently Shared on September 6, 2011 at 8:32 am By:
Azacitidine/pegfilgrastim: Various toxicities in elderly patients: 2 case reports: (Source: Reactions) http://t.co/QdH8JTa
Comparison of fixed dose pegfilgrastim and daily f... [Hematol Oncol. 2010] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on December 3, 2010 at 2:49 pm By:
Robert Z. Orlowski Physician, Doctor, and Internist
Italian study: Stem cell transplantation can be performed safely on outpatient basis for folks with multiple myeloma (http://bit.ly/fdqewE).
Pegfilgrastim to accelerate neutrophil engraftment... [Leuk Lymphoma. 2011] - PubMed result
ncbi.nlm.nih.gov — “PubMed is a service of the U.S. National Library of Medicine that includes over 19 million citations from MEDLINE and other life science journals for biomedical articles back to the 1950s. PubMed includes links to full text articles and other related resources.” View full resource at ncbi.nlm.nih.gov
Most Recently Shared on February 18, 2011 at 11:47 pm By:
Robert Z. Orlowski Physician, Doctor, and Internist
Neulasta helps myeloma patients recover neutrophils more quickly after stem cell transplantation that Neupogen (http://bit.ly/fxOwho).
Teva Announces Data on Granulocyte Colony Stimulating Factor Compounds for the Prevention of Chemotherapy-Induced Neutropenia in Breast Cancer Patients - Drugs.com MedNews
drugs.com — “CG-10639 (formerly Neugranin) Phase II III data demonstrated non-inferiority to pegfilgrastim Dosing study of XM22 supported future Phase III trial of 6mg dose” View full resource at drugs.com
Most Recently Shared on June 1, 2011 at 8:02 pm By:
Drugs and Devices OW OW Health
Teva Announces Data on Granulocyte Colony Stimulating Factor Compounds for the Prevention of Chemotherapy-... http://bit.ly/lQE2OV #drug
Oncology Article | Lymphoma
mdlinx.com — “Pegfilgrastim primary prophylaxis in patients with non-Hodgkin lymphoma: Results from an integrated analysis” View full resource at mdlinx.com
Most Recently Shared on January 27, 2011 at 9:37 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Pegfilgrastim primary prophylaxis in patients with non-Hodgkin lymphoma: Results from an integrated an... http://bit.ly/g4a2RL #oncology
Oncology Article | Leukopenia
mdlinx.com — “Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia” View full resource at mdlinx.com
Most Recently Shared on February 22, 2011 at 10:50 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced l... http://bit.ly/ezN2Ub #oncology
Ob/Gyn Article - Breast Neoplasms
mdlinx.com — “Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study” View full resource at mdlinx.com
Most Recently Shared on October 29, 2010 at 2:45 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in pa... http://bit.ly/dqsfaS #OBG
Use of Granulocyte Colony-Stimulating Factor in Patients With Severe Sepsis or Septic Shock - QualityPoint Technologies
qualitypointtech.net — “Does filgrastim or pegfilgrastim decrease mortality in patients with sepsis? American Journal of Health-System Pharmacy” View full resource at qualitypointtech.net
Most Recently Shared on August 19, 2010 at 11:00 am By:
Use of Granulocyte Colony-Stimulating Factor in Patients With Severe Sepsis or Septic Shock: Does filgrastim or pe... http://bit.ly/dBfVLk
Oncology Article | Lymphoma
mdlinx.com — “Breakthrough Febrile Neutropenia and Associated Complications in Non-Hodgkin's Lymphoma Patients Receiving Pegfilgrastim” View full resource at mdlinx.com
Most Recently Shared on December 15, 2010 at 12:14 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Breakthrough Febrile Neutropenia and Associated Complications in Non-Hodgkin's Lymphoma Patients Recei... http://bit.ly/hKFrcF #oncology
Erlotinib Dosing In Lung Cancer Depends On Smoking Status
medicalnewstoday.com — “Although erlotinib is an approved second-line therapy for lung cancer, its management is complicated by side effects that get worse as the dose increases. increased doses may lead to bet” View full resource at medicalnewstoday.com
Most Recently Shared on January 14, 2010 at 1:06 am By:
Erlotinib Dosing In Lung Cancer Depends On Smoking Status http://mnt.to/3wfm
Oncology Medical News about Sarcoma
mdlinx.com — “Phase II, randomized, open-label study of pegfilgrastim-supported VDC/IE chemotherapy in pediatric sarcoma patients” View full resource at mdlinx.com
Most Recently Shared on February 11, 2010 at 11:53 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Oncology Phase II, randomized, open-label study of pegfilgrastim-supported VDC/IE chemotherapy in pediatric sarcom... http://bit.ly/ahAfWi
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Toxins OW
Organizing toxins and chemicals resources shared by health experts, advocates, and organizations into WisdomCards.
-
Robert Z. Orlowski
Director of Myeloma Section at M. D. Anderson Cancer Center; Translational researcher who hates myeloma
Advertisement
